Androgens, ageing and vascular function

Age and Ageing

Volumn 37, Issue 4, 2008, Pages 361-363

  Getov, S V ^a,b   Lee, R W ^a,b   Dockery, F ^c   Rajkumar, C ^a,b  

^a Department of Medicine ^*  (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; ESTROGEN DERIVATIVE; HEMOGLOBIN; TESTOSTERONE;

AGING; ANDROPAUSE; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ARTERY COMPLIANCE; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DOPING; EDITORIAL; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOGONADISM; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; MUSCLE MASS; NON INVASIVE MEASUREMENT; OSTEOLYSIS; PHYSICAL DISEASE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PULSE WAVE; Q WAVE; RISK FACTOR; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; STROKE; SUDDEN DEATH; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; AGING; ANDROGENS; ARTERIOSCLEROSIS; HUMANS; MORBIDITY; RISK FACTORS;

EID: 47049085512     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn125     Document Type: Editorial

References (28)

1. Bhasin S, Buckwalter JG. Testosterone supplementation in older men: A rational idea whose time has not yet come. J Androl 2001; 22: 718-31.
2. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003; 24: 183-217.
3. Sullivan ML, Martinez CM, Gennis P et al. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998; 41: 1-15.
4. Dockery F, Bulpitt CJ, Donaldson M et al. The relationship between androgens and arterial stiffness in older men. J Am Geriatr Soc 2003; 51: 1627-32.
5. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82: 357-62.
6. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients. Hypertension 2001; 37: 1236-41.
7. Yasmin, Brown MJ. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. Q J Med 1999; 92: 595-600.
8. Liu Z, Brin KP, Yin FC. Estimation of total arterial compliance: An improved method and evaluation of current methods. Am J Physiol Heart Circ Physiol 1986; 251: 588-600.
9. Gosse P, Lasserre R, Minifie C et al. Arterial stiffness evaluated bymeasurement of the QKD interval is an independent predictor of cardiovascular events. Am J Hypertens 2005; 18: 470-6.
10. Nair N, Oka RK, Waring LD et al. Vascular compliance versus flow-mediated dilatation: Correlation with cardiovascular risk factors. Vasc Med 2005; 10: 275-83.
11. Wilkinson IB, MacCallum H, Cockcroft JR et al. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002; 53: 189-92.
12. Stewart AD, Millasseau SC, Kearney MT et al. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Hypertension 2003; 42: 915-8.
13. Bulpitt CJ, Rajkumar C, Cameron JD. Vascular compliance as a measure of biological age. J Am Geriatr Soc 1999; 47: 657-63.
14. Rossouw JE. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
15. Haddad RM, Kennedy CC, Caples SM et al. Testosterone and cardiovascular risk in men: A systematic review and metaanalysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 29-39.
16. Lane HA, Grace F, Smith JC et al. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 2006; 36: 483-8.
17. McCredie RJ, McCrohon JA, Turner L et al. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol 1998; 32: 1331-5.
18. Ong PJL, Patrizi G, Chong WCF et al. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 2000; 85: 269-72.
19. Dockery F, Bulpitt CJ, Agarwal S et al. Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci 2003; 104: 195-201.
20. Swartz CM, Young MA. Low serum testosterone and myocardial infarction in geriatric male inpatients. J Am Geriatr Soc 1987; 35: 39-44.
21. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronaemia with coronary artery disease in men. Arterioscler Thromb 1994; 14: 701-6.
22. Webb CM, Elkington AG, Kraidly MM et al. Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am J Cardiol 2008; 101: 618-24, Epub 2007 Dec 21.
23. English KM, Steeds RP, Jones TH et al. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation 2000; 102: 1906-11.
24. Ishihara F, Hiramatsu K, Shigematsu S et al. Role of adrenal androgens in the development of arteriosclerosis as judged by pulse wave velocity and calcification of the aorta. Cardiology 1992; 80: 332-8.
25. Hougaku H, Fleg JL, Najjar SS et al. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 2006; 290: E234-42.
26. Perheentupa A, Huhtaniemi I. Does the andropause exist? Nat Clin Pract Endocrinol Metab 2007; 3: 670-1.
27. Emmelot-Vonk MH, Verhaar HJ,Nakhai Pour HR et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: A randomized controlled trial. JAMA 2008; 299: 39-52.
28. Isidori AM, Giannetta E, Greco EA et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis. Clin Endocrinol 2005; 63: 280-93.